Skip to main content

Advertisement

SpringerLink
Log in

A changing paradigm in industrial pharmaceutical crystallization

  • Comment
  • Published:

From Nature Chemical Engineering

View current issue Submit your manuscript

Crystallization plays a pivotal role in the manufacturing of pharmaceuticals. This Comment briefly reflects on past achievements and emerging opportunities in industrial crystallization, particularly considering increasing molecular and system complexities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cote, A. et al. Cryst. Growth Des. 20, 7568–7581 (2020).

    Article  CAS  Google Scholar 

  2. Analysis Group for PhRMA Innovation in the Biopharmaceutical Pipeline (Pharmaceutical Research and Manufacturers of America, 2021).

  3. dos Santos, R., Carvalho, A. L. & Roque, A. C. A. Biotechnol. Adv. 35, 41–50 (2017).

    Article  PubMed  Google Scholar 

  4. Puhl, S., Meinel, L. & Germershaus, O. Asian J. Pharm. Sci. 11, 469–477 (2016).

    Article  Google Scholar 

  5. Verma, V., Bade, I., Karde, V. & Heng, J. Y. Y. Pharmaceutics 15, 1288 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chen, W. et al. Cryst. Growth Des. 20, 866–873 (2020).

    Article  CAS  Google Scholar 

  7. Li, X. & Heng, J. Y. Y. Chem. Eng. Res. Des. 173, 81–88 (2021).

    Article  CAS  Google Scholar 

  8. Li, X. & Heng, J. Y. Y. CrystEngComm 23, 8386–8391 (2021).

    Article  CAS  Google Scholar 

  9. Capellades, G., Bonsu, J. O. & Myerson, A. S. CrystEngComm 24, 1989–2001 (2022).

    Article  CAS  Google Scholar 

  10. Nordstrom, F. L. et al. Org. Process Res. Dev. 27, 723–741 (2023).

    Article  CAS  Google Scholar 

  11. Simon, L. L. et al. Org. Process Res. Dev. 19, 3–62 (2015).

    Article  CAS  Google Scholar 

  12. Xiouras, C. et al. Chem. Rev. 122, 13006–13042 (2022).

    Article  CAS  PubMed  Google Scholar 

  13. Lovette, M. A. et al. Cryst. Growth Des. 22, 5239–5263 (2022).

    Article  CAS  Google Scholar 

  14. Landis, S., Zhao, Y. & Doherty, M. F. Comput. Chem. Eng. 133, 106637 (2020).

    Article  CAS  Google Scholar 

  15. Richard, A. M. Chem. Res. Toxicol. 19, 1257–1262 (2006).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gilead Sciences Inc., Foster City, CA, USA

    Stefani Kocevska

  2. Eli Lilly and Company, Indianapolis, IN, USA

    Christopher L. Burcham

  3. Boehringer Ingelheim, Ridgefield, CT, USA

    Fredrik Nordstrom

  4. Bayer AG, Leverkusen, Germany

    Giovanni Maria Maggioni

Authors
  1. Stefani Kocevska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher L. Burcham
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fredrik Nordstrom
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni Maria Maggioni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Stefani Kocevska, Christopher L. Burcham, Fredrik Nordstrom or Giovanni Maria Maggioni.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kocevska, S., Burcham, C.L., Nordstrom, F. et al. A changing paradigm in industrial pharmaceutical crystallization. Nat Chem Eng 1, 327–329 (2024). https://doi.org/10.1038/s44286-024-00068-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44286-024-00068-8

  • Springer Nature America, Inc.

Search

Navigation